Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Catherine Lomen‐Hoerth
Sign up to set email alerts
155
Publications
5,355
Citation Statements Received
4,006
Citation Statements Given
How they've been cited
7,807
197
5,126
32
How they cite others
4,799
109
3,863
34
Affiliations
University of California, San Francisco
,
University of California San Francisco Medical Center
Publications
Order By: Most citations
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
van Rheenen
1
,
Shatunov
2
,
Dekker
3
et al.
2016
Nat Genet
Abstract
Show
673
13
545
3
Get access via publisher
Add to collection
Cite
The overlap of amyotrophic lateral sclerosis and frontotemporal dementia
Lomen‐Hoerth
1
,
Anderson
2
,
Miller
3
2002
Neurology
Abstract
Show
712
12
432
1
Get access via publisher
Add to collection
Cite
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
van Rheenen
1
,
van der Spek
2
,
Bakker
3
et al.
2021
Nat Genet
Abstract
Show
611
18
373
0
3
Get access via publisher
Add to collection
Cite
TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease
Rayaprolu
1
,
Mullen
2
,
Baker
3
et al.
2013
Mol Neurodegeneration
Abstract
Show
439
4
323
1
Get access via publisher
Add to collection
Cite
Comparison of family histories in FTLD subtypes and related tauopathies
Goldman
1
,
Farmer
2
,
Wood
3
et al.
2005
Neurology
Abstract
Show
374
2
265
2
Get access via publisher
Add to collection
Cite
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
Bril
1
,
Drużdż
2
,
Großkreutz
3
et al.
2023
The Lancet Neurology
303
8
177
1
1
Get access via publisher
Add to collection
Cite
Comprehensive cell type decomposition of circulating cell-free DNA with CelFiE
Caggiano
1
,
Celona
2
,
Garton
3
et al.
2021
Nat Commun
Abstract
Show
114
6
138
4
Get access via publisher
Add to collection
Cite
Ataxin-2 repeat-length variation and neurodegeneration
Ross
1
,
Rutherford
2
,
Baker
3
et al.
2011
Human Molecular Genetics
Abstract
Show
174
3
143
0
Get access via publisher
Add to collection
Cite
1
2
3